In the ALI animal model, intervention with acacetin suppressed the expression of the M1 markers iNOS and CD86 and reduced the levels of proinflammatory cytokines such as TNF-α, IL-1β, and IL-6. The gene discussed is IL6; the disease is acute respiratory distress syndrome.